Monocyte homeostasis and the plasticity of inflammatory monocytes

Cellular Immunology

Volumn 291, Issue 1-2, 2014, Pages 22-31

  Mitchell, Andrew J ^a   Roediger, Ben ^a   Weninger, Wolfgang ^a,b,c  

^a CENTENARY INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Homeostasis; Inflammation; Macrophage; Monocyte

Indexed keywords

CYTOKINE;

ANIMAL CELL; ARTICLE; BONE MARROW; HOMEOSTASIS; INFLAMMATION; MICROENVIRONMENT; MONOCYTE; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; PLASTICITY; ANIMAL; CELL LINEAGE; CYTOLOGY; HUMAN; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL LINEAGE; HOMEOSTASIS; HUMANS; INFLAMMATION; MICE; MONOCYTES;

EID: 84908504771     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.05.010     Document Type: Article

References (166)

1. van Furth R., Cohn Z.A., Hirsch J.G., Humphrey J.H., Spector W.G., Langevoort H.L. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull. World Health Organ. 1972, 46:845-852.
2. van Furth R., Cohn Z.A. The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 1968, 128:415-435.
3. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., Samokhvalov I.M., Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
4. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., Prinz M., Wu B., Jacobsen S.E., Pollard J.W., Frampton J., Liu K.J., Geissmann F. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336:86-90.
5. Guilliams M., De Kleer I., Henri S., Post S., Vanhoutte L., De Prijck S., Deswarte K., Malissen B., Hammad H., Lambrecht B.N. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 2013, 210:1977-1992.
6. Yona S., Kim K.-W., Wolf Y., Mildner A., Varol D., Breker M., Strauss-Ayali D., Viukov S., Guilliams M., Misharin A., Hume David A., Perlman H., Malissen B., Zelzer E., Jung S. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013, 38:79-91.
7. Kierdorf K., Erny D., Goldmann T., Sander V., Schulz C., Perdiguero E.G., Wieghofer P., Heinrich A., Riemke P., Holscher C., Muller D.N., Luckow B., Brocker T., Debowski K., Fritz G., Opdenakker G., Diefenbach A., Biber K., Heikenwalder M., Geissmann F., Rosenbauer F., Prinz M. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 2013, 16:273-280.
8. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 2009, 27:669-692.
9. Cortez-Retamozo V., Etzrodt M., Newton A., Rauch P.J., Chudnovskiy A., Berger C., Ryan R.J.H., Iwamoto Y., Marinelli B., Gorbatov R., Forghani R., Novobrantseva T.I., Koteliansky V., Figueiredo J.-L., Chen J.W., Anderson D.G., Nahrendorf M., Swirski F.K., Weissleder R., Pittet M.J. Origins of tumor-associated macrophages and neutrophils. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:2491-2496.
10. Cortez-Retamozo V., Etzrodt M., Newton A., Ryan R., Pucci F., Sio Selena W., Kuswanto W., Rauch Philipp J., Chudnovskiy A., Iwamoto Y., Kohler R., Marinelli B., Gorbatov R., Wojtkiewicz G., Panizzi P., Mino-Kenudson M., Forghani R., Figueiredo J.-L., Chen John W., Xavier R., Swirski Filip K., Nahrendorf M., Weissleder R., Pittet Mikael J. Angiotensin II drives the production of tumor-promoting macrophages. Immunity 2013, 38:296-308.
11. Leuschner F., Rauch P.J., Ueno T., Gorbatov R., Marinelli B., Lee W.W., Dutta P., Wei Y., Robbins C., Iwamoto Y., Sena B., Chudnovskiy A., Panizzi P., Keliher E., Higgins J.M., Libby P., Moskowitz M.A., Pittet M.J., Swirski F.K., Weissleder R., Nahrendorf M. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J. Exp. Med. 2012, 209:123-137.
12. Dutta P., Courties G., Wei Y., Leuschner F., Gorbatov R., Robbins C.S., Iwamoto Y., Thompson B., Carlson A.L., Heidt T., Majmudar M.D., Lasitschka F., Etzrodt M., Waterman P., Waring M.T., Chicoine A.T., van der Laan A.M., Niessen H.W., Piek J.J., Rubin B.B., Butany J., Stone J.R., Katus H.A., Murphy S.A., Morrow D.A., Sabatine M.S., Vinegoni C., Moskowitz M.A., Pittet M.J., Libby P., Lin C.P., Swirski F.K., Weissleder R., Nahrendorf M. Myocardial infarction accelerates atherosclerosis. Nature 2012, 487:325-329.
13. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000, 404:193-197.
14. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R., Cumano A., Geissmann F. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311:83-87.
15. Hettinger J., Richards D.M., Hansson J., Barra M.M., Joschko A.C., Krijgsveld J., Feuerer M. Origin of monocytes and macrophages in a committed progenitor. Nat. Immunol. 2013, 14:821-830.
16. Lawrence T., Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 2011, 11:750-761.
17. Geissmann F., Gordon S., Hume D.A., Mowat A.M., Randolph G.J. Unravelling mononuclear phagocyte heterogeneity. Nat. Rev. Immunol. 2010, 10:453-460.
18. Sieweke M.H., Allen J.E. Beyond stem cells: self-renewal of differentiated macrophages. Science 2013, 342:1242974.
19. Sunderkotter C., Nikolic T., Dillon M.J., Van Rooijen N., Stehling M., Drevets D.A., Leenen P.J. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 2004, 172:4410-4417.
20. Ingersoll M.A., Spanbroek R., Lottaz C., Gautier E.L., Frankenberger M., Hoffmann R., Lang R., Haniffa M., Collin M., Tacke F., Habenicht A.J.R., Ziegler-Heitbrock L., Randolph G.J. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 2010, 115:e10-e19.
21. Hume D.A., Pavli P., Donahue R.E., Fidler I.J. The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo. J. Immunol. 1988, 141:3405-3409.
22. Weiner L.M., Li W., Holmes M., Catalano R.B., Dovnarsky M., Padavic K., Alpaugh R.K. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant γ-interferon: toxicity, monocytosis, and clinical effects. Cancer Res. 1994, 54:4084-4090.
23. Ulich T., del Castillo J., Watson L., Yin S., Garnick M. In vivo hematologic effects of recombinant human macrophage colony- stimulating factor. Blood 1990, 75:846-850.
24. Ryan G.R., Dai X.M., Dominguez M.G., Tong W., Chuan F., Chisholm O., Russell R.G., Pollard J.W., Stanley E.R. Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 2001, 98:74-84.
25. Wiktor-Jedrzejczak W.W., Ahmed A., Szczylik C., Skelly R.R. Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J. Exp. Med. 1982, 156:1516-1527.
26. Dai X.M., Ryan G.R., Hapel A.J., Dominguez M.G., Russell R.G., Kapp S., Sylvestre V., Stanley E.R. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002, 99:111-120.
27. Hibbs M.L., Quilici C., Kountouri N., Seymour J.F., Armes J.E., Burgess A.W., Dunn A.R. Mice lacking three myeloid colony-stimulating factors (G-CSF, GM-CSF, and M-CSF) still produce macrophages and granulocytes and mount an inflammatory response in a serile model of peritonitis. J. Immunol. 2007, 178:6435-6443.
28. Lagasse E., Weissman I.L. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 1997, 89:1021-1031.
29. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 2008, 8:533-544.
30. Bartocci A., Mastrogiannis D.S., Migliorati G., Stockert R.J., Wolkoff A.W., Stanley E.R. Macrophages specifically regulate the concentration of their own growth factor in the circulation. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:6179-6183.
31. Tushinski R.J., Oliver I.T., Guilbert L.J., Tynan P.W., Warner J.R., Stanley E.R. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 1982, 28:71-81.
32. Lieschke G., Stanley E., Grail D., Hodgson G., Sinickas V., Gall J., Sinclair R., Dunn A. Mice lacking both macrophage- and granulocyte-macrophage colony- stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. Blood 1994, 84:27-35.
33. Dai X.M., Zong X.H., Sylvestre V., Stanley E.R. Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1. Blood 2004, 103:1114-1123.
34. Nilsson S., Lieschke G., Garcia-Wijnen C., Williams B., Tzelepis D., Hodgson G., Grail D., Dunn A., Bertoncello I. Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse. Blood 1995, 86:66-72.
35. Lenzo J.C., Turner A.L., Cook A.D., Vlahos R., Anderson G.P., Reynolds E.C., Hamilton J.A. Control of macrophage lineage populations by CSF-1 receptor and GM-CSF in homeostasis and inflammation. Immunol. Cell Biol. 2012, 90:429-440.
36. Harris S.E., MacDougall M., Horn D., Woodruff K., Zimmer S.N., Rebel V.I., Fajardo R., Feng J.Q., Gluhak-Heinrich J., Harris M.A., Abboud Werner S. Meox2Cre-mediated disruption of CSF-1 leads to osteopetrosis and osteocyte defects. Bone 2012, 50:42-53.
37. Lin H., Lee E., Hestir K., Leo C., Huang M., Bosch E., Halenbeck R., Wu G., Zhou A., Behrens D., Hollenbaugh D., Linnemann T., Qin M., Wong J., Chu K., Doberstein S.K., Williams L.T. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008, 320:807-811.
38. Ma X., Lin W.Y., Chen Y., Stawicki S., Mukhyala K., Wu Y., Martin F., Bazan J.F., Starovasnik M.A. Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R. Structure 2012, 20:676-687.
39. Chihara T., Suzu S., Hassan R., Chutiwitoonchai N., Hiyoshi M., Motoyoshi K., Kimura F., Okada S. IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death Differ. 2010, 17:1917-1927.
40. Barve R.A., Zack M.D., Weiss D., Song R.-H., Beidler D., Head R.D. Transcriptional profiling and pathway analysis of CSF-1 and IL-34 effects on human monocyte differentiation. Cytokine 2013, 63:10-17.
41. Wang Y., Szretter K.J., Vermi W., Gilfillan S., Rossini C., Cella M., Barrow A.D., Diamond M.S., Colonna M. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 2012.
42. Satpathy A.T., Wu X., Albring J.C., Murphy K.M. Re(de)fining the dendritic cell lineage. Nat. Immunol. 2012, 13:1145-1154.
43. Doherty T.M., Coffman R.L. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major. J. Immunol. 1993, 150:5476-5483.
44. Tadokoro C.E., de Almeida Abrahamsohn I. Bone marrow-derived macrophages grown in GM-CSF or M-CSF differ in their ability to produce IL-12 and to induce IFN-γ production after stimulation with Trypanosoma cruzi antigens. Immunol. Lett. 2001, 77:31-38.
45. Stanley E., Lieschke G.J., Grail D., Metcalf D., Hodgson G., Gall J.A., Maher D.W., Cebon J., Sinickas V., Dunn A.R. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. 1994, 91:5592-5596.
46. Burgess A.W., Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 1980, 56:947-958.
47. Gasson J. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 1991, 77:1131-1145.
48. Campbell I.K., van Nieuwenhuijze A., Segura E., O'Donnell K., Coghill E., Hommel M., Gerondakis S., Villadangos J.A., Wicks I.P. Differentiation of inflammatory dendritic cells is mediated by NF-kB1-dependent GM-CSF production in CD4 T Cells. J. Immunol. 2011, 186:5468-5477.
49. Codarri L., Gyulveszi G., Tosevski V., Hesske L., Fontana A., Magnenat L., Suter T., Becher B. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011, 12:560-567.
50. El-Behi M., Ciric B., Dai H., Yan Y., Cullimore M., Safavi F., Zhang G.X., Dittel B.N., Rostami A. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011, 12:568-575.
51. Hercus T.R., Broughton S.E., Ekert P.G., Ramshaw H.S., Perugini M., Grimbaldeston M., Woodcock J.M., Thomas D., Pitson S., Hughes T., D'Andrea R.J., Parker M.W., Lopez A.F. The GM-CSF receptor family: mechanism of activation and implications for disease. Growth Factors 2012, 30:63-75.
52. Zhou Y., Stanley E., Clark S., Hatzfeld J., Levesque J., Federici C., Watt S., Hatzfeld A. Interleukin-3 and interleukin-1 alpha allow earlier bone marrow progenitors to respond to human colony-stimulating factor 1. Blood 1988, 72:1870-1874.
53. Okayama Y., Kawakami T. Development, migration, and survival of mast cells. Immunol. Res. 2006, 34:97-115.
54. Jenkins S.J., Ruckerl D., Thomas G.D., Hewitson J.P., Duncan S., Brombacher F., Maizels R.M., Hume D.A., Allen J.E. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J. Exp. Med. 2013, 210:2477-2491.
55. Jenkins S.J., Ruckerl D., Cook P.C., Jones L.H., Finkelman F.D., van Rooijen N., MacDonald A.S., Allen J.E. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011, 332:1284-1288.
56. Bunting K.D., Yu W.-M., Bradley H.L., Haviernikova E., Kelly-Welch A.E., Keegan A.D., Qu C.-K. Increased numbers of committed myeloid progenitors but not primitive hematopoietic stem/progenitors in mice lacking STAT6 expression. J. Leukoc. Biol. 2004, 76:484-490.
57. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
58. Auffray C., Fogg D., Garfa M., Elain G., Join-Lambert O., Kayal S., Sarnacki S., Cumano A., Lauvau G., Geissmann F. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007, 317:666-670.
59. Ziegler-Heitbrock H.W.L. Heterogeneity of human blood monocytes: the CD14+CD16+ subpopulation. Immunol. Today 1996, 17:424-428.
60. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., Leenen P.J.M., Liu Y.-J., MacPherson G., Randolph G.J., Scherberich J., Schmitz J., Shortman K., Sozzani S., Strobl H., Zembala M., Austyn J.M., Lutz M.B. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.
61. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J. Leukoc. Biol. 2007, 81:584-592.
62. Cros J., Cagnard N., Woollard K., Patey N., Zhang S.-Y., Senechal B., Puel A., Biswas S.K., Moshous D., Picard C., Jais J.-P., D'Cruz D., Casanova J.-L., Trouillet C., Geissmann F. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010, 33:375-386.
63. Passlick B., Flieger D., Ziegler-Heitbrock H.W. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989, 74:2527-2534.
64. Wong K.L., Tai J.J.-Y., Wong W.-C., Han H., Sem X., Yeap W.-H., Kourilsky P., Wong S.-C. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011, 118:e16-e31.
65. Hanna R.N., Carlin L.M., Hubbeling H.G., Nackiewicz D., Green A.M., Punt J.A., Geissmann F., Hedrick C.C. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat. Immunol. 2011, 12:778-785.
66. Tacke F., Ginhoux F., Jakubzick C., van Rooijen N., Merad M., Randolph G.J. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J. Exp. Med. 2006, 203:583-597.
67. Varol C., Landsman L., Fogg D.K., Greenshtein L., Gildor B., Margalit R., Kalchenko V., Geissmann F., Jung S. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 2007, 204:171-180.
68. MacDonald K.P., Palmer J.S., Cronau S., Seppanen E., Olver S., Raffelt N.C., Kuns R., Pettit A.R., Clouston A., Wainwright B., Branstetter D., Smith J., Paxton R.J., Cerretti D.P., Bonham L., Hill G.R., Hume D.A. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. Blood 2010, 116:3955-3963.
69. Serbina N.V., Jia T., Hohl T.M., Pamer E.G. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 2008, 26:421-452.
70. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 2011, 11:762-774.
71. Jakubzick C., Gautier E.L., Gibbings S.L., Sojka D.K., Schlitzer A., Johnson T.E., Ivanov S., Duan Q., Bala S., Condon T., van Rooijen N., Grainger J.R., Belkaid Y., Ma'ayan A., Riches D.W., Yokoyama W.M., Ginhoux F., Henson P.M., Randolph G.J. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity 2013, 39:599-610.
72. Tamoutounour S., Guilliams M., Montanana Sanchis F., Liu H., Terhorst D., Malosse C., Pollet E., Ardouin L., Luche H., Sanchez C., Dalod M., Malissen B., Henri S. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 2013, 39:925-938.
73. Nahrendorf M., Swirski F.K., Aikawa E., Stangenberg L., Wurdinger T., Figueiredo J.-L., Libby P., Weissleder R., Pittet M.J. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 2007, 204:3037-3047.
74. Shechter R., Miller O., Yovel G., Rosenzweig N., London A., Ruckh J., Kim K.-W., Klein E., Kalchenko V., Bendel P., Lira Sergio A., Jung S., Schwartz M. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 2013, 38:555-569.
75. Hanna R.N., Shaked I., Hubbeling H.G., Punt J.A., Wu R., Herrley E., Zaugg C., Pei H., Geissmann F., Ley K., Hedrick C.C. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ. Res. 2012, 110:416-427.
76. Hamers A.A.J., Vos M., Rassam F., Marinković G., Kurakula K., van Gorp P.J., de Winther M.P.J., Gijbels M.J.J., de Waard V., de Vries C.J.M. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circ. Res. 2012, 110:428-438.
77. Carlin L.M., Stamatiades E.G., Auffray C., Hanna R.N., Glover L., Vizcay-Barrena G., Hedrick C.C., Cook H.T., Diebold S., Geissmann F. Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell 2013, 153:362-375.
78. Biburger M., Aschermann S., Schwab I., Lux A., Albert H., Danzer H., Woigk M., Dudziak D., Nimmerjahn F. Monocyte subsets responsible for immunoglobulin G-dependent effector functions in-vivo. Immunity 2011, 35:932-944.
79. Santiago-Raber M.L., Amano H., Amano E., Baudino L., Otani M., Lin Q., Nimmerjahn F., Verbeek J.S., Ravetch J.V., Takasaki Y., Hirose S., Izui S. Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice. Arthritis Rheum. 2009, 60:2408-2417.
80. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., Figueiredo J.L., Kohler R.H., Chudnovskiy A., Waterman P., Aikawa E., Mempel T.R., Libby P., Weissleder R., Pittet M.J. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
81. Jacquelin S., Licata F., Dorgham K., Hermand P., Poupel L., Guyon E., Deterre P., Hume D.A., Combadière C., Boissonnas A. CX3CR1 reduces Ly6Chigh-monocyte motility within and release from the bone marrow after chemotherapy in mice. Blood 2013, 122:674-683.
82. Debien E., Mayol K., Biajoux V., Daussy C., De Aguero M.G., Taillardet M., Dagany N., Brinza L., Henry T., Dubois B., Kaiserlian D., Marvel J., Balabanian K., Walzer T. S1PR5 is pivotal for the homeostasis of patrolling monocytes. Eur. J. Immunol. 2013, 43:1667-1675.
83. Struyf S., Van Collie E., Paemen L., Put W., Lenaerts J.P., Proost P., Opdenakker G., Van Damme J. Synergistic induction of MCP-1 and -2 by IL-1beta and interferons in fibroblasts and epithelial cells. J. Leukoc. Biol. 1998, 63:364-372.
84. Rollins B.J., Pober J.S. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am. J. Pathol. 1991, 138:1315-1319.
85. Brown Z., Gerritsen M.E., Carley W.W., Strieter R.M., Kunkel S.L., Westwick J. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. Am. J. Pathol. 1994, 145:913-921.
86. Thompson W.L., Van Eldik L.J. Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-7 through NFκB and MAPK dependent pathways in rat astrocytes. Brain Res. 2009, 1287:47-57.
87. Yoo J.K., Kwon H., Khil L.-Y., Zhang L., Jun H.-S., Yoon J.-W. IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways. J. Immunol. 2005, 175:8280-8286.
88. Shi C., Jia T., Mendez-Ferrer S., Hohl T.M., Serbina N.V., Lipuma L., Leiner I., Li M.O., Frenette P.S., Pamer E.G. Bone marrow mesenchymal stem and progenitor cells Induce monocyte emigration in response to circulating Toll-like receptor ligands. Immunity 2011, 34:590-601.
89. Wang Y., Cui L., Gonsiorek W., Min S.H., Anilkumar G., Rosenblum S., Kozlowski J., Lundell D., Fine J.S., Grant E.P. CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis. J. Inflamm. (Lond.) 2009, 6:32.
90. Tsou C.L., Peters W., Si Y., Slaymaker S., Aslanian A.M., Weisberg S.P., Mack M., Charo I.F. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 2007, 117:902-909.
91. Serbina N.V., Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 2006, 7:311-317.
92. Jia T., Serbina N.V., Brandl K., Zhong M.X., Leiner I.M., Charo I.F., Pamer E.G. Additive rRoles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. J. Immunol. 2008, 180:6846-6853.
93. Nguyen K.D., Fentress S.J., Qiu Y., Yun K., Cox J.S., Chawla A. Circadian gene Bmal1 regulates diurnal oscillations of Ly6Chi inflammatory monocytes. Science 2013, 341:1483-1488.
94. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature 2002, 418:935-941.
95. Shi C., Velazquez P., Hohl T.M., Leiner I., Dustin M.L., Pamer E.G. Monocyte trafficking to hepatic sites of bacterial infection is chemokine independent and directed by focal intercellular adhesion molecule-1 expression. J. Immunol. 2010, 184:6266-6274.
96. Soehnlein O., Drechsler M., Döring Y., Lievens D., Hartwig H., Kemmerich K., Ortega-Gómez A., Mandl M., Vijayan S., Projahn D., Garlichs C.D., Koenen R.R., Hristov M., Lutgens E., Zernecke A., Weber C. Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes. EMBO Mol. Med. 2013, 5:471-481.
97. Hashimoto D., Chow A., Noizat C., Teo P., Beasley M.B., Leboeuf M., Becker C.D., See P., Price J., Lucas D., Greter M., Mortha A., Boyer S.W., Forsberg E.C., Tanaka M., van Rooijen N., Garcìa-Sastre A., Stanley E.R., Ginhoux F., Frenette P.S., Merad M. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013, 38:792-804.
98. Ajami B., Bennett J.L., Krieger C., Tetzlaff W., Rossi F.M.V. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 2007, 10:1538-1543.
99. Mildner A., Schmidt H., Nitsche M., Merkler D., Hanisch U.-K., Mack M., Heikenwalder M., Bruck W., Priller J., Prinz M. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci. 2007, 10:1544-1553.
100. Mukouyama Y., Chiba N., Mucenski M.L., Satake M., Miyajima A., Hara T., Watanabe T. Hematopoietic cells in cultures of the murine embryonic aorta-gonad-mesonephros region are induced by c-Myb. Curr. Biol. 1999, 9:833-836.
101. Sumner R., Crawford A., Mucenski M., Frampton J. Initiation of adult myelopoiesis can occur in the absence of c-Myb whereas subsequent development is strictly dependent on the transcription factor. Oncogene 2000, 19:3335-3342.
102. Sawyer R.T. The ontogeny of pulmonary alveolar macrophages in parabiotic mice. J. Leukoc. Biol. 1986, 40:347-354.
103. Bogunovic M., Ginhoux F., Helft J., Shang L., Hashimoto D., Greter M., Liu K., Jakubzick C., Ingersoll M.A., Leboeuf M., Stanley E.R., Nussenzweig M., Lira S.A., Randolph G.J., Merad M. Origin of the lamina propria dendritic cell network. Immunity 2009, 31:513-525.
104. Varol C., Vallon-Eberhard A., Elinav E., Aychek T., Shapira Y., Luche H., Fehling H.J., Hardt W.D., Shakhar G., Jung S. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009, 31:502-512.
105. Bain C.C., Scott C.L., Uronen-Hansson H., Gudjonsson S., Jansson O., Grip O., Guilliams M., Malissen B., Agace W.W., Mowat A.M. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 2013, 6:498-510.
106. Rivollier A., He J., Kole A., Valatas V., Kelsall B.L. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 2012, 209:139-155.
107. Abtin A., Jain R., Mitchell A.J., Roediger B., Brzoska A.J., Tikoo S., Cheng Q., Ng L.G., Cavanagh L.L., von Andrian U.H., Hickey M.J., Firth N., Weninger W. Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection. Nat. Immunol. 2014, 15:45-53.
108. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007, 7:19-30.
109. Segura E., Amigorena S. Inflammatory dendritic cells in mice and humans. Trends Immunol. 2013, 34:440-445.
110. Nakano H., Lin K.L., Yanagita M., Charbonneau C., Cook D.N., Kakiuchi T., Gunn M.D. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat. Immunol. 2009, 10:394-402.
111. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59-70.
112. Van Dyken S.J., Locksley R.M. Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu. Rev. Immunol. 2013, 31:317-343.
113. Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 1992, 176:287-292.
114. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122:787-795.
115. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008, 13:453-461.
116. Scharton T.M., Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 1993, 178:567-577.
117. Kupz A., Guarda G., Gebhardt T., Sander L.E., Short K.R., Diavatopoulos D.A., Wijburg O.L.C., Cao H., Waithman J.C., Chen W., Fernandez-Ruiz D., Whitney P.G., Heath W.R., Curtiss R., Tschopp J., Strugnell R.A., Bedoui S. NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8+ T cells. Nat. Immunol. 2012, 13:162-169.
118. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986, 136:2348-2357.
119. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15:323-350.
120. Serbina N.V., Kuziel W., Flavell R., Akira S., Rollins B., Pamer E.G. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 2003, 19:891-901.
121. Copin R., De Baetselier P., Carlier Y., Letesson J.-J., Muraille E. MyD88-dependent activation of B220-CD11b+LY-6C+ dendritic cells during Brucella melitensis infection. J. Immunol. 2007, 178:5182-5191.
122. Fei M., Bhatia S., Oriss T.B., Yarlagadda M., Khare A., Akira S., Saijo S., Iwakura Y., Fallert Junecko B.A., Reinhart T.A., Foreman O., Ray P., Kolls J., Ray A. TNF-α from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5360-5365.
123. Bosschaerts T., Guilliams M., Stijlemans B., Morias Y., Engel D., Tacke F., Hérin M., De Baetselier P., Beschin A. Tip-DC development during parasitic infection Is regulated by IL-10 and requires CCL2/CCR2, IFN-γ and MyD88 signaling. PLoS Pathog. 2010, 6:e1001045.
124. De Trez C., Magez S., Akira S., Ryffel B., Carlier Y., Muraille E. INOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog. 2009, 5:e1000494.
125. León B., López-Bravo M., Ardavín C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T pelper 1 responses against Leishmania. Immunity 2007, 26:519-531.
126. Aldridge J.R., Moseley C.E., Boltz D.A., Negovetich N.J., Reynolds C., Franks J., Brown S.A., Doherty P.C., Webster R.G., Thomas P.G. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5306-5311.
127. Siddiqui K.R.R., Laffont S., Powrie F. E-Cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis. Immunity 2010, 32:557-567.
128. Ji Q., Castelli L., Goverman J.M. MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8(+) T cells. Nat. Immunol. 2013, 14:254-261.
129. Roediger B., Kyle R., Yip K.H., Sumaria N., Guy T.V., Kim B.S., Mitchell A.J., Tay S.S., Jain R., Forbes-Blom E., Chen X., Tong P.L., Bolton H.A., Artis D., Paul W.E., Fazekas de St Groth B., Grimbaldeston M.A., Le Gros G., Weninger W. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat. Immunol. 2013, 14:564-573.
130. Egawa M., Mukai K., Yoshikawa S., Iki M., Mukaida N., Kawano Y., Minegishi Y., Karasuyama H. Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity 2013, 38:570-580.
131. Cherwinski H.M., Schumacher J.H., Brown K.D., Mosmann T.R. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 1987, 166:1229-1244.
132. Fleetwood A.J., Dinh H., Cook A.D., Hertzog P.J., Hamilton J.A. GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on Type I interferon signaling. J. Leukoc. Biol. 2009, 86:411-421.
133. Fleetwood A.J., Lawrence T., Hamilton J.A., Cook A.D. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 2007, 178:5245-5252.
134. Verreck F.A.W., de Boer T., Langenberg D.M.L., Hoeve M.A., Kramer M., Vaisberg E., Kastelein R., Kolk A., de Waal-Malefyt R., Ottenhoff T.H.M. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4560-4565.
135. Falk L.A., Wahl L.M., Vogel S.N. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor. J. Immunol. 1988, 140:2652-2660.
136. Fischer H.G., Frosch S., Reske K., Reske-Kunz A.B. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. J. Immunol. 1988, 141:3882-3888.
137. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 2006, 177:7303-7311.
138. Krausgruber T., Blazek K., Smallie T., Alzabin S., Lockstone H., Sahgal N., Hussell T., Feldmann M., Udalova I.A. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 2011, 12:231-238.
139. Zhan Y., Lieschke G.J., Grail D., Dunn A.R., Cheers C. Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice. Blood 1998, 91:863-869.
140. Riopel J., Tam M., Mohan K., Marino M.W., Stevenson M.M. Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria. Infect. Immun. 2001, 69:129-136.
141. LeVine A.M., Reed J.A., Kurak K.E., Cianciolo E., Whitsett J.A. GM-CSF-deficient mice are susceptible to pulmonary group B Streptococcal infection. J. Clin. Invest. 1999, 103:563-569.
142. Gonzalez-Juarrero M., Hattle J.M., Izzo A., Junqueira-Kipnis A.P., Shim T.S., Trapnell B.C., Cooper A.M., Orme I.M. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J. Leukoc. Biol. 2005, 77:914-922.
143. Szeliga J., Daniel D.S., Yang C.-H., Sever-Chroneos Z., Jagannath C., Chroneos Z.C. Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis. Tuberculosis 2008, 88:7-20.
144. Greter M., Helft J., Chow A., Hashimoto D., Mortha A., Agudo-Cantero J., Bogunovic M., Gautier E.L., Miller J., Leboeuf M., Lu G., Aloman C., Brown B.D., Pollard J.W., Xiong H., Randolph G.J., Chipuk J.E., Frenette P.S., Merad M. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but Is dispensable for the differentiation of inflammatory dendritic cells. Immunity 2012, 36:1031-1046.
145. Jaguin M., Houlbert N., Fardel O., Lecureur V. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell. Immunol. 2013, 281:51-61.
146. Scotton C.J., Martinez F.O., Smelt M.J., Sironi M., Locati M., Mantovani A., Sozzani S. Transcriptional profiling reveals complex regulation of the monocyte IL-1β system by IL-13. J. Immunol. 2005, 174:834-845.
147. Chaitidis P., O'Donnell V., Kuban R.J., Bermudez-Fajardo A., Ungethuem U., Kuhn H. Gene expression alterations of human peripheral blood monocytes induced by medium-term treatment with the TH2-cytokines interleukin-4 and -13. Cytokine 2005, 30:366-377.
148. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R.M., Aguet M. Immune response in mice that lack the interferon-gamma receptor. Science 1993, 259:1742-1745.
149. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993, 259:1739-1742.
150. Zhang S.-Y., Boisson-Dupuis S., Chapgier A., Yang K., Bustamante J., Puel A., Picard C., Abel L., Jouanguy E., Casanova J.-L. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-α/β, IFN-γ, and IFN-λ in host defense. Immunol. Rev. 2008, 226:29-40.
151. Lykens J.E., Terrell C.E., Zoller E.E., Divanovic S., Trompette A., Karp C.L., Aliberti J., Flick M.J., Jordan M.B. Mice with a selective impairment of IFN-γ signaling in macrophage lineage cells demonstrate the critical role of IFN-γ-activated macrophages for the control of protozoan parasitic infections in vivo. J. Immunol. 2010, 184:877-885.
152. Magez S., Radwanska M., Drennan M., Fick L., Baral T.N., Brombacher F., De Baetselier P. Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during Trypanosoma congolense Tc13 Infections. J. Infect. Dis. 2006, 193:1575-1583.
153. Sheldon K.E., Shandilya H., Kepka-Lenhart D., Poljakovic M., Ghosh A., Morris S.M. Shaping the murine macrophage phenotype: IL-4 and cyclic AMP synergistically activate the arginase I promoter. J. Immunol. 2013, 191:2290-2298.
154. Bronte V., Zanovello P. Regulation of immune responses by l-arginine metabolism. Nat. Rev. Immunol. 2005, 5:641-654.
155. Modolell M., Corraliza I.M., Link F., Soler G., Eichmann K. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH 1 and TH 2 cytokines. Eur. J. Immunol. 1995, 25:1101-1104.
156. Munder M., Eichmann K., Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance. competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 1998, 160:5347-5354.
157. Munder M., Choi B.S., Rogers M., Kropf P. l-Arginine deprivation impairs Leishmania major-specific T-cell responses. Eur. J. Immunol. 2009, 39:2161-2172.
158. Kropf P., Baud D., Marshall S.E., Munder M., Mosley A., Fuentes J.M., Bangham C.R.M., Taylor G.P., Herath S., Choi B.-S., Soler G., Teoh T., Modolell M., Müller I. Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur. J. Immunol. 2007, 37:935-945.
159. Pesce J.T., Ramalingam T.R., Mentink-Kane M.M., Wilson M.S., El Kasmi K.C., Smith A.M., Thompson R.W., Cheever A.W., Murray P.J., Wynn T.A. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009, 5:e1000371.
160. Davies L.C., Rosas M., Jenkins S.J., Liao C.-T., Scurr M.J., Brombacher F., Fraser D.J., Allen J.E., Jones S.A., Taylor P.R. Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation. Nat. Commun. 2013, 4:1886.
161. Arnold L., Henry A., Poron F.o., Baba-Amer Y., van Rooijen N., Plonquet A., Gherardi R.K., Chazaud B.n.d. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 2007, 204:1057-1069.
162. Ramachandran P., Pellicoro A., Vernon M.A., Boulter L., Aucott R.L., Ali A., Hartland S.N., Snowdon V.K., Cappon A., Gordon-Walker T.T., Williams M.J., Dunbar D.R., Manning J.R., van Rooijen N., Fallowfield J.A., Forbes S.J., Iredale J.P. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E3186-E3195.
163. Mitchell A.J., Pradel L.C., Chasson L., Van Rooijen N., Grau G.E., Hunt N.H., Chimini G. Technical advance. Autofluorescence as a tool for myeloid cell analysis. J. Leukoc. Biol. 2010, 88:597-603.
164. Davies L.C., Rosas M., Smith P.J., Fraser D.J., Jones S.A., Taylor P.R. A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation. Eur. J. Immunol. 2011, 41:2155-2164.
165. Pradel L.C., Mitchell A.J., Zarubica A., Dufort L., Chasson L., Naquet P., Broccardo C., Chimini G. ATP-binding cassette transporter hallmarks tissue macrophages and modulates cytokine-triggered polarization programs. Eur. J. Immunol. 2009, 39:2270-2280.
166. Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S., Helft J., Chow A., Elpek K.G., Gordonov S., Mazloom A.R., Ma'ayan A., Chua W.-J., Hansen T.H., Turley S.J., Merad M., Randolph G.J. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012, 13:1118-1128.